These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 14681512)
21. Finasteride to prevent morbidity from benign prostatic hyperplasia. Wasson JH N Engl J Med; 1998 Feb; 338(9):612-3. PubMed ID: 9475770 [No Abstract] [Full Text] [Related]
22. 5alpha-reductase inhibition for men with enlarged prostate. Issa MM; Kraft KH J Am Acad Nurse Pract; 2007 Aug; 19(8):398-407. PubMed ID: 17655569 [TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare-aged men. Issa MM; Lin PJ; Eaddy MT; Shah MB; Davis EA Am J Manag Care; 2008 May; 14(5 Suppl 2):S160-6. PubMed ID: 18611090 [TBL] [Abstract][Full Text] [Related]
24. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia. DiSantostefano RL; Biddle AK; Lavelle JP Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487 [No Abstract] [Full Text] [Related]
25. Finasteride in benign prostatic hyperplasia. Wysowski DK; Farinas E N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649 [No Abstract] [Full Text] [Related]
26. Benign prostatic hyperplasia (BPH). Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474 [No Abstract] [Full Text] [Related]
27. Breakthrough treatment for prostate enlargement. Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965 [No Abstract] [Full Text] [Related]
28. Advances in the medical management of benign prostatic hyperplasia. Jewett MA; Klotz LH; CMAJ; 2007 Jun; 176(13):1850-1. PubMed ID: 17576985 [No Abstract] [Full Text] [Related]
30. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function. Kaplan SA Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431 [No Abstract] [Full Text] [Related]
31. Benign prostatic hyperplasia--review of treatment options. Oehlke KJ; Branaugh ML S D Med; 2009 May; 62(5):202-3. PubMed ID: 19489345 [No Abstract] [Full Text] [Related]
33. A new take on prostate drugs. Johns Hopkins Med Lett Health After 50; 1998 Apr; 10(2):1-2. PubMed ID: 9552801 [No Abstract] [Full Text] [Related]
34. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia. Agha AH; Roy JB; Culkin DJ; Lyon K Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological options in the treatment of benign prostatic hyperplasia. Kenny B; Ballard S; Blagg J; Fox D J Med Chem; 1997 Apr; 40(9):1293-315. PubMed ID: 9135028 [No Abstract] [Full Text] [Related]
36. Medical treatment of benign prostatic hyperplasia. Schmidt JD West J Med; 1991 Dec; 155(6):633. PubMed ID: 1725942 [No Abstract] [Full Text] [Related]
37. Second opinion. I have benign prostatic hyperplasia. The drug my doctor prescribed has helped somewhat, but I'm still making a lot of trips to the bathroom at night. Short of surgery, are there any new approaches to managing this condition that might be more helpful? Mayo Clin Health Lett; 2002 Dec; 20(12):8. PubMed ID: 12526112 [No Abstract] [Full Text] [Related]
38. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. Roehrborn CG BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681 [TBL] [Abstract][Full Text] [Related]
39. Benign prostatic hyperplasia: from A - Z. Elhilali MM; Nickel JC Can J Urol; 2003 Apr; 10(2):1799-802. PubMed ID: 12773230 [TBL] [Abstract][Full Text] [Related]
40. Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. Marberger M Nat Clin Pract Urol; 2006 Sep; 3(9):495-503. PubMed ID: 16964191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]